What is a Demonstration Project?
The Project Santa Fe Foundation promotes Clinical Lab 2.0, a laboratory model where laboratory diagnostics are integrated proactively into clinical workflows to support population health management. Demonstration Projects are single and multi-site research projects designed to evaluate the value of the clinical laboratory professional in achieving better patient outcomes and delivery of cost-effective health care. The target outcome of a Demonstration Project is promotion of better healthcare delivery, value creation for health organizations, and improved clinical and financial outcomes.
How are Demonstration Projects identified by the Project Santa Fe Foundation?
CL2.0 Demonstration Projects are developed to solve problems relevant to the healthcare system(s) by focusing on conditions/issues/or diseases that have high prevalence in the population. Common diseases such as diabetes, chronic kidney disease, and cardiovascular disease are a few examples of high prevalence/high cost conditions, for which clinical laboratory leadership and intervention can have a positive impact.
Who can Participate in Demonstration Projects?
Initially, Project Santa Fe Foundation members participated in Demonstration Projects. Currently, organizations outside of the Project Santa Fe Foundation can participate either by invitation or by expressing interest. Organizations interested in Demonstration Projects need the following infrastructure to support the projects:
- Laboratory teamwork with institutional stakeholders outside the laboratory
- Alignment of institutional priorities with the project problem being identified and solved
- Data Science capabilities
- Can be completed in 12 to 24 months
What have we learned from Demonstration Projects?
Demonstrating the value of the laboratory professional and longitudinal laboratory data is challenging and complex. Healthcare quality and total cost of care can be impacted by a wide variety of interventions that may not necessarily reflect the work completed by the laboratory. One clear measure of the laboratory’s value can be the identification of gaps in care when compared to national treatment guidelines, early identification of disease before it is documented in the medical record, and risk stratification of patients to identify sub-groups with the highest need for support. Accruing quantitative metrics and outcomes that can be attributed to laboratory involvement requires rigorous project design, and teamwork among the multi-disciplinary members of the project team. The CL2.0 demonstration projects that have reached completion are excellent examples of the value that can be demonstrated for the clinical laboratory.
Want to learn more?
Please contact Kathy Swanson and she’ll bring you into the conversation.